Editorial: Model organisms in renal pharmacology: 2022

Frontiers in Pharmacology

Pharmacology

Ayman M. Mahmoud¹  Rajesh Nachiappa Ganesh²  Weiqiang Lin³  Vikram Patial⁴  Pragasam Viswanathan⁵ 

[1] Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, United Kingdom;Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt;Department of Pathology, JIPMER, Puducherry, India;Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Academic Institute, Houston, TX, United States;International Institutes of Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China;Pharmacology and Toxicology Laboratory, Dietetics & Nutrition Technology, CSIR-Institute of Himalayan Bioresource Technology, Palampur, India;Renal Research Lab, Centre for Bio-Medical Research, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India;

关键词: chronic kidney disesase;    nephropathy;    renal fibrosis;    animals models;    extracellular vescicles;   

DOI  :  10.3389/fphar.2023.1139806

 received in 2023-01-07, accepted in 2023-02-01,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Mahmoud, Lin, Patial, Nachiappa Ganesh and Viswanathan.